Medicare Advantage value-based design expanded for 2019

Fifteen new states will participate in the Medicare Advantage (MA) Value-Based Insurance Design (VBID) model for 2019, allowing insurers in a total of 25 states to enter the program aimed at encouraging enrollees to focus on services that are of the highest clinical value to their specific chronic conditions.

States where the model will now be available in 2019 are: California, Colorado, Florida, Georgia, Hawaii, Maine, Minnesota, Montana, New Jersey, New Mexico, North Carolina, North Dakota, South Dakota, Virginia and West Virginia. For 2018, insurers were allowed to apply to participate in Alabama, Arizona, Indiana, Iowa, Massachusetts, Michigan, Oregon, Pennsylvania, Tennessee and Texas.

“This administration is committed to making sure that our seniors have more choices and lower premiums in their Medicare Advantage plans,” CMS Administrator Seema Verma, MPH, said in a statement. “CMS expects that this demonstration will provide insights into future innovations for the Medicare Advantage program.”

Other changes announced for the VBID model in 2019 were similar to “flexibilities” on benefit design for MA and Medicare Part D included in a recent proposed rule from CMS. Chronic Conditions Special Needs plans will be allowed to participate in the model, enrolling beneficiaries with different chronic conditions than CMS had previously included, including lower back pain, chronic kidney disease, obesity/pre-diabetes, asthma, and tobacco use.

MA plans which want to participate in the VBID model in 2019 will need to request and then complete an application by Jan. 26, 2018. Current participants will also need to reapply by the same date.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?